As a leading expert in biopharma and technological innovation, Ivan Kairatov has dedicated his career to the intersection of health and R&D. Today, we delve into a groundbreaking study where artificial intelligence analyzed WhatsApp voice messages to detect major depressive disorder, a condition
The fight against hereditary cancer has long been a reactive battle waged with scalpels and surveillance, but a landmark clinical trial now suggests a future where the body's own immune system can be trained to intercept the disease before it ever takes root. Recent findings for an investigational
The path from discovering a suspicious breast lump to receiving a definitive diagnosis is often fraught with anxiety, culminating in a biopsy that, for a vast majority of individuals, confirms the lesion is benign. In the United States alone, an astonishing 75% to 80% of all breast biopsies yield
In a significant move that could reshape the landscape of cardiovascular medicine for millions of Americans, a comprehensive bipartisan appropriations bill is advancing through Congress, carrying with it major implications for how patients access care and how the nation invests in medical research.
We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and research is pushing the boundaries of what’s possible in patient care. We'll be exploring a groundbreaking AI-powered wearable that translates silent throat movements into fluent speech for
Artificial intelligence has made remarkable strides in recognizing human emotions from facial expressions and tone of voice, but a groundbreaking new framework is now aiming for a far more ambitious goal: computationally modeling how emotions are formed in the first place. Researchers in Japan have
